Steven Gilman

Steven Gilman

Direktor/Vorstandsmitglied bei SCYNEXIS, INC.

Vermögen: 166 250 $ am 31.05.2026

73 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Steven C.
Gilman
is an Independent Director at SCYNEXIS, Inc. since 2015.
Holds Director positions at the Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former roles include Vice Chairman at ContraFect Corp.
from 2019 to 2023; Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Massachusetts Biotechnology Council, Nextcea, Inc., and other firms; Scientist at Wyeth LLC; Principal at Connecticut College and Temple University School of Medicine; General Manager at Inflammation Research Association, Inc. Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
10.06.2025 152.830 ( 0,06 % ) 155 887 $ 31.05.2026
01.04.2026 14.700 ( 0,02 % ) 10 364 $ 31.05.2026

Aktive Positionen von Steven Gilman

UnternehmenPositionBeginn
SCYNEXIS, INC. Direktor/Vorstandsmitglied 25.02.2015
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 07.07.2009
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Steven Gilman

UnternehmenPositionEnde
AKEBIA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.04.2026
VERICEL CORPORATION Direktor/Vorstandsmitglied 30.04.2025
CONTRAFECT CORPORATION Vorstandsvorsitzender 02.04.2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Steven Gilman im Detail an

Ausbildung von Steven Gilman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Börse
  2. Insiders
  3. Steven Gilman
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT